TreeWAS – Variant ID: rs1053051

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T40.2 Other opioids	0.023	0.977	0.000
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.021	0.979	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.021	0.979	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.020	0.980	0.000
T40.6 Other and unspecified narcotics	0.017	0.983	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.017	0.983	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.016	0.984	0.000
T40.3 Methadone	0.015	0.985	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
T40.4 Other synthetic narcotics	0.015	0.985	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.015	0.985	0.000
T40.8 Lysergide [LSD]	0.015	0.985	0.000
T40.7 Cannabis (derivatives)	0.015	0.985	0.000
T40.5 Cocaine	0.015	0.985	0.000
T40.0 Opium	0.015	0.985	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.015	0.985	0.000
T42.1 Iminostilbenes	0.014	0.986	0.000
T40.1 Heroin	0.013	0.986	0.000
N97.9 Female infertility, unspecified	0.000	0.986	0.014
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.013	0.987	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.013	0.987	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.013	0.987	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.013	0.987	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
T50.1 Loop [high-ceiling] diuretics	0.012	0.988	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.012	0.988	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.012	0.988	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.012	0.988	0.000
T39.0 Salicylates	0.012	0.988	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.012	0.988	0.000
T50.8 Diagnostic agents	0.012	0.988	0.000
T36 Poisoning by systemic antibiotics	0.012	0.988	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.012	0.988	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.012	0.988	0.000
T47.6 Antidiarrhoeal drugs	0.011	0.988	0.000
K70.9 Alcoholic liver disease, unspecified	0.012	0.988	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.011	0.988	0.000
T47.4 Other laxatives	0.011	0.989	0.000
T50.7 Analeptics and opioid receptor antagonists	0.011	0.989	0.000
T50.5 Appetite depressants	0.011	0.989	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.011	0.989	0.000
T50.0 Mineralocorticoids and their antagonists	0.011	0.989	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.989	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.011	0.989	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.011	0.989	0.000
T47.7 Emetics	0.011	0.989	0.000
T47.5 Digestants	0.011	0.989	0.000
T47.3 Saline and osmotic laxatives	0.011	0.989	0.000
T47.2 Stimulant laxatives	0.011	0.989	0.000
T47.0 Histamine H(2)-receptor antagonists	0.011	0.989	0.000
R09 Other symptoms and signs involving the circulatory and respiratory systems	0.011	0.989	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.011	0.989	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.010	0.990	0.000
H50.9 Strabismus, unspecified	0.000	0.990	0.010
T46.1 Calcium-channel blockers	0.010	0.990	0.000
J92.9 Pleural plaque without asbestos	0.010	0.990	0.000
N62 Hypertrophy of breast	0.000	0.990	0.010
T38.1 Thyroid hormones and substitutes	0.010	0.990	0.000
T42.0 Hydantoin derivatives	0.010	0.990	0.000
R09.0 Asphyxia	0.010	0.990	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.010	0.990	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.010	0.990	0.000
T46.7 Peripheral vasodilators	0.010	0.990	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.010	0.990	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.990	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.010	0.990	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.990	0.000
T38.7 Androgens and anabolic congeners	0.009	0.990	0.000
T38.5 Other oestrogens and progestogens	0.009	0.990	0.000
T38.4 Oral contraceptives	0.009	0.990	0.000
T38.2 Antithyroid drugs	0.009	0.990	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.990	0.000
K70 Alcoholic liver disease	0.010	0.990	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
T36.4 Tetracyclines	0.009	0.991	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.009	0.991	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.009	0.991	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
T36.3 Macrolides	0.009	0.991	0.000
T39.4 Antirheumatics, not elsewhere classified	0.009	0.991	0.000
T39.2 Pyrazolone derivatives	0.009	0.991	0.000
T41.5 Therapeutic gases	0.009	0.991	0.000
T41.4 Anaesthetic, unspecified	0.009	0.991	0.000
T41.3 Local anaesthetics	0.009	0.991	0.000
T41.2 Other and unspecified general anaesthetics	0.009	0.991	0.000
T41.1 Intravenous anaesthetics	0.009	0.991	0.000
T41.0 Inhaled anaesthetics	0.009	0.991	0.000
R09.2 Respiratory arrest	0.009	0.991	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.009	0.991	0.000
T37.5 Antiviral drugs	0.009	0.991	0.000
T37.4 Anthelminthics	0.009	0.991	0.000
T37.3 Other antiprotozoal drugs	0.009	0.991	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.009	0.991	0.000
T37.1 Antimycobacterial drugs	0.009	0.991	0.000
T37.0 Sulphonamides	0.009	0.991	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.009	0.991	0.000
K70.1 Alcoholic hepatitis	0.009	0.991	0.000
T36.9 Systemic antibiotic, unspecified	0.009	0.991	0.000
T36.8 Other systemic antibiotics	0.009	0.991	0.000
T36.7 Antifungal antibiotics, systemically used	0.009	0.991	0.000
T36.6 Rifamycins	0.009	0.991	0.000
T36.5 Aminoglycosides	0.009	0.991	0.000
T36.2 Chloramphenicol group	0.009	0.991	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
T49.9 Topical agent, unspecified	0.008	0.991	0.000
T49.8 Other topical agents	0.008	0.991	0.000
T49.7 Dental drugs, topically applied	0.008	0.991	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.991	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.991	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.991	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.991	0.000
T49.2 Local astringents and local detergents	0.008	0.991	0.000
T49.1 Antipruritics	0.008	0.991	0.000
K70.0 Alcoholic fatty liver	0.009	0.991	0.000
R04.0 Epistaxis	0.009	0.991	0.000
F10.3 Withdrawal state	0.008	0.992	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
R09.3 Abnormal sputum	0.008	0.992	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.008	0.992	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.992	0.000
T48.5 Anti-common-cold drugs	0.008	0.992	0.000
T48.4 Expectorants	0.008	0.992	0.000
T48.3 Antitussives	0.008	0.992	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.992	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.992	0.000
T48.0 Oxytocic drugs	0.008	0.992	0.000
K70.4 Alcoholic hepatic failure	0.008	0.992	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.007	0.993	0.000
T45.8 Other primarily systemic and haematological agents	0.007	0.993	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.007	0.993	0.000
T45.6 Fibrinolysis-affecting drugs	0.007	0.993	0.000
T45.4 Iron and its compounds	0.007	0.993	0.000
T45.3 Enzymes, not elsewhere classified	0.007	0.993	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.007	0.993	0.000
Q61.3 Polycystic kidney, unspecified	0.000	0.993	0.007
T36.0 Penicillins	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.993	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.006	0.993	0.001
T43.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.993	0.000
K70.3 Alcoholic cirrhosis of liver	0.006	0.994	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.006	0.994	0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.994	0.006
T45.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
X62.9 Unspecified place	0.006	0.994	0.000
T45.5 Anticoagulants	0.006	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
F17.2 Dependence syndrome	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.005	0.995	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.995	0.001
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.001
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.001
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.995	0.001
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.995	0.001
T44.0 Anticholinesterase agents	0.004	0.995	0.001
F10 Mental and behavioural disorders due to use of alcohol	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.995	0.001
A40.8 Other streptococcal septicaemia	0.000	0.995	0.005
T42.4 Benzodiazepines	0.005	0.995	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.995	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.995	0.005
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
F10.2 Dependence syndrome	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.995	0.001
R04 Haemorrhage from respiratory passages	0.005	0.995	0.000
Z73.3 Stress, not elsewhere classified	0.000	0.995	0.005
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.995	0.001
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.004	0.996	0.000
F11 Mental and behavioural disorders due to use of opioids	0.004	0.996	0.000
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.996	0.004
F10.5 Psychotic disorder	0.004	0.996	0.000
R04.1 Haemorrhage from throat	0.004	0.996	0.000
H18.8 Other specified disorders of cornea	0.004	0.996	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.996	0.004
F17.9 Unspecified mental and behavioural disorder	0.004	0.996	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.996	0.004
H47.3 Other disorders of optic disk	0.000	0.996	0.004
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.004	0.996	0.000
F11.2 Dependence syndrome	0.004	0.996	0.000
F17.0 Acute intoxication	0.004	0.996	0.000
F10.4 Withdrawal state with delirium	0.004	0.996	0.000
F10.8 Other mental and behavioural disorders	0.004	0.996	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.004	0.996	0.000
F17.8 Other mental and behavioural disorders	0.004	0.996	0.000
F17.7 Residual and late-onset psychotic disorder	0.004	0.996	0.000
F17.6 Amnesic syndrome	0.004	0.996	0.000
F17.5 Psychotic disorder	0.004	0.996	0.000
F17.4 Withdrawal state with delirium	0.004	0.996	0.000
K63.1 Perforation of intestine (nontraumatic)	0.000	0.996	0.004
Y83.3 Surgical operation with formation of external stoma	0.000	0.996	0.004
F17.3 Withdrawal state	0.004	0.996	0.000
H47.1 Papilloedema, unspecified	0.000	0.996	0.004
F14 Mental and behavioural disorders due to use of cocaine	0.004	0.996	0.000
R47.1 Dysarthria and anarthria	0.000	0.996	0.004
F10.6 Amnesic syndrome	0.004	0.996	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.004	0.996	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.004	0.996	0.000
R04.9 Haemorrhage from respiratory passages, unspecified	0.004	0.996	0.000
Q61 Cystic kidney disease	0.000	0.996	0.004
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.004	0.996	0.000
S64.3 Injury of digital nerve of thumb	0.000	0.996	0.004
R04.8 Haemorrhage from other sites in respiratory passages	0.004	0.996	0.000
M00.94 Pyogenic arthritis, unspecified (Hand)	0.004	0.996	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.004	0.996	0.000
F11.1 Harmful use	0.003	0.996	0.000
X62.8 Other specified place	0.003	0.996	0.000
F13.2 Dependence syndrome	0.003	0.996	0.000
G71.1 Myotonic disorders	0.000	0.996	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
R01.1 Cardiac murmur, unspecified	0.000	0.997	0.003
F10.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.003	0.997	0.000
X62.0 Home	0.003	0.997	0.000
X62.7 Farm	0.003	0.997	0.000
X62.6 Industrial and construction area	0.003	0.997	0.000
X62.5 Trade and service area	0.003	0.997	0.000
X62.4 Street and highway	0.003	0.997	0.000
X62.3 Sports and athletics area	0.003	0.997	0.000
X62.2 School, other institution and public administrative area	0.003	0.997	0.000
X62.1 Residential institution	0.003	0.997	0.000
F11.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F11.8 Other mental and behavioural disorders	0.003	0.997	0.000
F11.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F11.6 Amnesic syndrome	0.003	0.997	0.000
F11.5 Psychotic disorder	0.003	0.997	0.000
F11.4 Withdrawal state with delirium	0.003	0.997	0.000
F11.0 Acute intoxication	0.003	0.997	0.000
H47.2 Optic atrophy	0.000	0.997	0.003
F10.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
M00.9 Pyogenic arthritis, unspecified	0.003	0.997	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.997	0.003
R04.2 Haemoptysis	0.003	0.997	0.000
F15.1 Harmful use	0.003	0.997	0.000
H47.7 Disorder of visual pathways, unspecified	0.000	0.997	0.003
H47.6 Disorders of visual cortex	0.000	0.997	0.003
H47.4 Disorders of optic chiasm	0.000	0.997	0.003
A40 Streptococcal septicaemia	0.000	0.997	0.003
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.000	0.997	0.003
F14.2 Dependence syndrome	0.003	0.997	0.000
G72.4 Inflammatory myopathy, not elsewhere classified	0.000	0.997	0.003
F13.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F13.8 Other mental and behavioural disorders	0.003	0.997	0.000
F13.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F13.6 Amnesic syndrome	0.003	0.997	0.000
F13.5 Psychotic disorder	0.003	0.997	0.000
F13.4 Withdrawal state with delirium	0.003	0.997	0.000
F13.3 Withdrawal state	0.003	0.997	0.000
F13.1 Harmful use	0.003	0.997	0.000
F13.0 Acute intoxication	0.003	0.997	0.000
Z34.0 Supervision of normal first pregnancy	0.000	0.997	0.003
F12.2 Dependence syndrome	0.003	0.997	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.003	0.997	0.000
G72 Other myopathies	0.000	0.997	0.003
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.003	0.997	0.000
F11.3 Withdrawal state	0.003	0.997	0.000
F19.2 Dependence syndrome	0.003	0.997	0.000
J92 Pleural plaque	0.003	0.997	0.000
F15.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F15.8 Other mental and behavioural disorders	0.003	0.997	0.000
F15.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F15.6 Amnesic syndrome	0.003	0.997	0.000
F15.5 Psychotic disorder	0.003	0.997	0.000
F15.4 Withdrawal state with delirium	0.003	0.997	0.000
F15.3 Withdrawal state	0.003	0.997	0.000
F15.2 Dependence syndrome	0.003	0.997	0.000
F15.0 Acute intoxication	0.003	0.997	0.000
G72.9 Myopathy, unspecified	0.000	0.997	0.003
H47.5 Disorders of other visual pathways	0.000	0.997	0.003
R03.1 Nonspecific low blood-pressure reading	0.003	0.997	0.000
F14.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F14.8 Other mental and behavioural disorders	0.003	0.997	0.000
F14.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F14.6 Amnesic syndrome	0.003	0.997	0.000
F14.5 Psychotic disorder	0.003	0.997	0.000
F14.4 Withdrawal state with delirium	0.003	0.997	0.000
F14.3 Withdrawal state	0.003	0.997	0.000
F14.0 Acute intoxication	0.003	0.997	0.000
G72.8 Other specified myopathies	0.000	0.997	0.003
X69.9 Unspecified place	0.003	0.997	0.000
X69.0 Home	0.003	0.997	0.000
N97 Female infertility	0.000	0.997	0.003
X60-X84 Intentional self-harm	0.003	0.997	0.000
A40.3 Septicaemia due to Streptococcus pneumoniae	0.000	0.997	0.003
F16.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F16.8 Other mental and behavioural disorders	0.003	0.997	0.000
F16.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F16.6 Amnesic syndrome	0.003	0.997	0.000
F16.5 Psychotic disorder	0.003	0.997	0.000
F16.4 Withdrawal state with delirium	0.003	0.997	0.000
F16.3 Withdrawal state	0.003	0.997	0.000
F16.2 Dependence syndrome	0.003	0.997	0.000
F16.1 Harmful use	0.003	0.997	0.000
F16.0 Acute intoxication	0.003	0.997	0.000
F18.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F18.8 Other mental and behavioural disorders	0.003	0.997	0.000
F18.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F18.6 Amnesic syndrome	0.003	0.997	0.000
F18.5 Psychotic disorder	0.003	0.997	0.000
F18.4 Withdrawal state with delirium	0.003	0.997	0.000
F18.3 Withdrawal state	0.003	0.997	0.000
F18.2 Dependence syndrome	0.003	0.997	0.000
F18.1 Harmful use	0.003	0.997	0.000
F18.0 Acute intoxication	0.003	0.997	0.000
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
Q61.8 Other cystic kidney diseases	0.000	0.997	0.003
Q61.1 Polycystic kidney, infantile type	0.000	0.997	0.003
H50 Other strabismus	0.000	0.997	0.003
F14.1 Harmful use	0.003	0.997	0.000
F19.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F19.8 Other mental and behavioural disorders	0.003	0.997	0.000
F19.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F19.6 Amnesic syndrome	0.003	0.997	0.000
F19.5 Psychotic disorder	0.003	0.997	0.000
F19.4 Withdrawal state with delirium	0.003	0.997	0.000
F19.3 Withdrawal state	0.003	0.997	0.000
F19.0 Acute intoxication	0.003	0.997	0.000
F12.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F12.8 Other mental and behavioural disorders	0.003	0.997	0.000
F12.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F12.6 Amnesic syndrome	0.003	0.997	0.000
F12.5 Psychotic disorder	0.003	0.997	0.000
F12.4 Withdrawal state with delirium	0.003	0.997	0.000
F12.3 Withdrawal state	0.003	0.997	0.000
F12.0 Acute intoxication	0.003	0.997	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.003	0.997	0.000
F17.1 Harmful use	0.003	0.997	0.000
M00.99 Pyogenic arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
H50.1 Divergent concomitant strabismus	0.000	0.997	0.003
S89.9 Unspecified injury of lower leg	0.000	0.997	0.003
F10.0 Acute intoxication	0.003	0.997	0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M00.92 Pyogenic arthritis, unspecified (Upper arm)	0.003	0.997	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.002	0.997	0.000
A40.9 Streptococcal septicaemia, unspecified	0.000	0.997	0.003
A40.2 Septicaemia due to streptococcus, group D	0.000	0.997	0.003
S93.0 Dislocation of ankle joint	0.003	0.997	0.000
G71 Primary disorders of muscles	0.000	0.997	0.003
A40.1 Septicaemia due to streptococcus, group B	0.000	0.997	0.003
Q61.4 Renal dysplasia	0.000	0.997	0.003
M00.98 Pyogenic arthritis, unspecified (Other)	0.003	0.997	0.000
G72.0 Drug-induced myopathy	0.000	0.997	0.003
Q61.9 Cystic kidney disease, unspecified	0.000	0.997	0.002
M00.93 Pyogenic arthritis, unspecified (Forearm)	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.997	0.001
M00.91 Pyogenic arthritis, unspecified (Shoulder region)	0.003	0.997	0.000
A40.0 Septicaemia due to streptococcus, group A	0.000	0.997	0.003
L57.0 Actinic keratosis	0.003	0.997	0.000
Q61.5 Medullary cystic kidney	0.000	0.997	0.002
X83 Intentional self-harm by other specified means	0.003	0.997	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Z93.5 Cystostomy status	0.003	0.997	0.000
M47.82 Other spondylosis (Cervical region)	0.003	0.997	0.000
F19.1 Harmful use	0.002	0.997	0.000
H50.4 Other and unspecified heterotropia	0.000	0.997	0.003
Z51.3 Blood transfusion without reported diagnosis	0.000	0.997	0.003
X69.8 Other specified place	0.002	0.997	0.000
X69.7 Farm	0.002	0.997	0.000
X69.6 Industrial and construction area	0.002	0.997	0.000
X69.5 Trade and service area	0.002	0.997	0.000
X69.4 Street and highway	0.002	0.997	0.000
X69.3 Sports and athletics area	0.002	0.997	0.000
X69.2 School, other institution and public administrative area	0.002	0.997	0.000
X69.1 Residential institution	0.002	0.997	0.000
M00.90 Pyogenic arthritis, unspecified (Multiple sites)	0.002	0.997	0.000
G72.3 Periodic paralysis	0.000	0.997	0.002
G72.2 Myopathy due to other toxic agents	0.000	0.997	0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.997	0.000
N97.4 Female infertility associated with male factors	0.000	0.997	0.002
S89.8 Other specified injuries of lower leg	0.000	0.997	0.002
G72.1 Alcoholic myopathy	0.000	0.998	0.002
N97.3 Female infertility of cervical origin	0.000	0.998	0.002
N97.2 Female infertility of uterine origin	0.000	0.998	0.002
G71.3 Mitochondrial myopathy, not elsewhere classified	0.000	0.998	0.002
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
X64.2 School, other institution and public administrative area	0.002	0.998	0.000
X83.9 Unspecified place	0.002	0.998	0.000
X61.2 School, other institution and public administrative area	0.002	0.998	0.000
N97.0 Female infertility associated with anovulation	0.000	0.998	0.002
S93.3 Dislocation of other and unspecified parts of foot	0.002	0.998	0.000
F12.1 Harmful use	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
D07.5 Prostate	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
H50.8 Other specified strabismus	0.000	0.998	0.002
K25.7 Chronic without haemorrhage or perforation	0.002	0.998	0.000
N97.8 Female infertility of other origin	0.000	0.998	0.002
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.000	0.998	0.002
G71.9 Primary disorder of muscle, unspecified	0.000	0.998	0.002
G71.8 Other primary disorders of muscles	0.000	0.998	0.002
G71.2 Congenital myopathies	0.000	0.998	0.002
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
H50.2 Vertical strabismus	0.000	0.998	0.002
Z96.7 Presence of other bone and tendon implants	0.000	0.998	0.002
G71.0 Muscular dystrophy	0.000	0.998	0.002
L93.0 Discoid lupus erythematosus	0.002	0.998	0.000
A87.9 Viral meningitis, unspecified	0.002	0.998	0.000
H50.3 Intermittent heterotropia	0.000	0.998	0.002
X61.9 Unspecified place	0.002	0.998	0.000
X61.8 Other specified place	0.002	0.998	0.000
X61.0 Home	0.002	0.998	0.000
X61.7 Farm	0.002	0.998	0.000
X61.6 Industrial and construction area	0.002	0.998	0.000
X61.5 Trade and service area	0.002	0.998	0.000
X61.4 Street and highway	0.002	0.998	0.000
X61.3 Sports and athletics area	0.002	0.998	0.000
X61.1 Residential institution	0.002	0.998	0.000
X64.9 Unspecified place	0.002	0.998	0.000
X64.0 Home	0.002	0.998	0.000
X64.8 Other specified place	0.002	0.998	0.000
X64.7 Farm	0.002	0.998	0.000
X64.6 Industrial and construction area	0.002	0.998	0.000
X64.5 Trade and service area	0.002	0.998	0.000
X64.4 Street and highway	0.002	0.998	0.000
X64.3 Sports and athletics area	0.002	0.998	0.000
X64.1 Residential institution	0.002	0.998	0.000
X83.8 Other specified place	0.002	0.998	0.000
X83.7 Farm	0.002	0.998	0.000
X83.6 Industrial and construction area	0.002	0.998	0.000
X83.5 Trade and service area	0.002	0.998	0.000
X83.4 Street and highway	0.002	0.998	0.000
X83.3 Sports and athletics area	0.002	0.998	0.000
X83.2 School, other institution and public administrative area	0.002	0.998	0.000
X83.1 Residential institution	0.002	0.998	0.000
X83.0 Home	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.002	0.998	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
S50.0 Contusion of elbow	0.000	0.998	0.002
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.998	0.002
S89 Other and unspecified injuries of lower leg	0.000	0.998	0.002
C83.3 Large cell (diffuse)	0.002	0.998	0.000
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000
X60.6 Industrial and construction area	0.002	0.998	0.000
X60.4 Street and highway	0.002	0.998	0.000
X60.3 Sports and athletics area	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
R09.1 Pleurisy	0.002	0.998	0.000
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X66.9 Unspecified place	0.002	0.998	0.000
X66.8 Other specified place	0.002	0.998	0.000
X66.7 Farm	0.002	0.998	0.000
X66.6 Industrial and construction area	0.002	0.998	0.000
X66.5 Trade and service area	0.002	0.998	0.000
X66.4 Street and highway	0.002	0.998	0.000
X66.3 Sports and athletics area	0.002	0.998	0.000
X66.2 School, other institution and public administrative area	0.002	0.998	0.000
X66.1 Residential institution	0.002	0.998	0.000
X66.0 Home	0.002	0.998	0.000
X70.8 Other specified place	0.002	0.998	0.000
X70.9 Unspecified place	0.002	0.998	0.000
X70.7 Farm	0.002	0.998	0.000
X70.6 Industrial and construction area	0.002	0.998	0.000
X70.5 Trade and service area	0.002	0.998	0.000
X70.4 Street and highway	0.002	0.998	0.000
X70.3 Sports and athletics area	0.002	0.998	0.000
X70.2 School, other institution and public administrative area	0.002	0.998	0.000
X70.1 Residential institution	0.002	0.998	0.000
X70.0 Home	0.002	0.998	0.000
X71.9 Unspecified place	0.002	0.998	0.000
X71.8 Other specified place	0.002	0.998	0.000
X71.7 Farm	0.002	0.998	0.000
X71.6 Industrial and construction area	0.002	0.998	0.000
X71.5 Trade and service area	0.002	0.998	0.000
X71.4 Street and highway	0.002	0.998	0.000
X71.3 Sports and athletics area	0.002	0.998	0.000
X71.2 School, other institution and public administrative area	0.002	0.998	0.000
X71.1 Residential institution	0.002	0.998	0.000
X71.0 Home	0.002	0.998	0.000
X72.9 Unspecified place	0.002	0.998	0.000
X72.8 Other specified place	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations